Albert Oriol Selected Research

Albert Oriol Research Topics

Disease

123	Multiple Myeloma 04/2024 - 10/2006
20	Neoplasms (Cancer) 10/2023 - 10/2007
14	Disease Progression 01/2024 - 11/2012
9	Pneumonia (Pneumonitis) 10/2023 - 11/2011
7	Thrombocytopenia (Thrombopenia) 10/2023 - 07/2012
7	Infections 10/2023 - 04/2003
7	Neutropenia 10/2023 - 07/2012
7	Residual Neoplasm 01/2023 - 01/2012
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 02/2003
7	Leukemia 10/2014 - 04/2003
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2016 - 05/2005
6	Lymphoma (Lymphomas) 12/2014 - 09/2002
6	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2014 - 04/2003
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2014 - 09/2005
5	Chromosome Aberrations (Chromosome Abnormalities) 10/2023 - 09/2007
5	Peripheral Nervous System Diseases (PNS Diseases) 08/2021 - 10/2010
5	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 11/2014 - 09/2002
5	Pathologic Complete Response 10/2010 - 10/2005
4	Sepsis (Septicemia) 10/2023 - 09/2019
4	Smoldering Multiple Myeloma 10/2022 - 08/2013
4	Fatigue 10/2017 - 06/2010
3	Septic Shock (Toxic Shock Syndrome) 10/2023 - 11/2011
3	Hypertension (High Blood Pressure) 12/2020 - 01/2016
3	Heart Arrest (Cardiac Arrest) 09/2019 - 10/2017
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2017 - 02/2008
3	Acquired Immunodeficiency Syndrome (AIDS) 03/2011 - 07/2005
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2007 - 04/2003
2	Plasmacytoma 09/2023 - 05/2019
2	Diarrhea 01/2023 - 12/2020
2	Body Weight (Weight, Body) 12/2022 - 11/2022
2	Circulating Neoplastic Cells 11/2022 - 01/2022
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 01/2022
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 11/2021 - 12/2020
2	Paraproteinemias (Monoclonal Gammopathy) 10/2021 - 08/2014
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 04/2017
2	Myocarditis (Carditis) 09/2019 - 09/2019
2	Respiratory Insufficiency (Respiratory Failure) 09/2019 - 11/2011
2	Immunoglobulin Light-chain Amyloidosis 01/2019 - 09/2015
2	Anemia 02/2017 - 10/2016
2	Philadelphia Chromosome 11/2012 - 01/2010
2	HIV Infections (HIV Infection) 07/2008 - 04/2003
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2007 - 10/2005
1	Frailty 11/2023

Drug/Important Bio-Agent (IBA)

66	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024 - 10/2007
39	Bortezomib (Velcade)FDA Link 02/2024 - 10/2006
39	Lenalidomide (CC 5013)FDA Link 11/2023 - 03/2011
21	pomalidomideIBA 03/2024 - 10/2013
20	daratumumabIBA 02/2024 - 04/2016
19	carfilzomibIBA 03/2024 - 01/2015
16	Prednisone (Sone)FDA LinkGeneric 08/2021 - 05/2005
12	Melphalan (Alkeran)FDA LinkGeneric 08/2021 - 10/2006
11	Proteasome InhibitorsIBA 10/2023 - 01/2015
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023 - 05/2005
10	Monoclonal AntibodiesIBA 01/2023 - 04/2016
9	Immunomodulating AgentsIBA 03/2024 - 09/2015
8	Thalidomide (Thalomid)FDA Link 01/2023 - 10/2010
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
8	Rituximab (Mabthera)FDA Link 11/2021 - 09/2002
7	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2019
6	Vincristine (Oncovin)FDA LinkGeneric 01/2016 - 05/2005
5	pembrolizumabIBA 04/2024 - 09/2019
5	isatuximabIBA 09/2023 - 01/2021
4	B-Cell Maturation AntigenIBA 09/2023 - 01/2021
4	melflufenIBA 08/2023 - 10/2020
4	Alkylating AgentsIBA 05/2021 - 09/2014
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 02/2008
3	AntibodiesIBA 10/2023 - 01/2020
3	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 09/2023 - 01/2021
3	Peptides (Polypeptides)IBA 08/2023 - 10/2020
3	ibrutinibIBA 11/2021 - 05/2020
3	Nerve Growth Factor (NGF)IBA 01/2021 - 10/2020
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2014 - 07/2004
2	Immunoglobulins (Immunoglobulin)IBA 11/2023 - 01/2020
2	Death Domain ReceptorsIBA 10/2023 - 01/2021
2	plitidepsin (aplidine)IBA 01/2023 - 06/2010
2	ParaproteinsIBA 01/2022 - 05/2019
2	AminopeptidasesIBA 01/2021 - 10/2020
2	idecabtagene vicleucelIBA 01/2021 - 01/2021
2	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2020
2	Decitabine FDA Link 01/2018 - 07/2012
2	fludarabineIBA 04/2017 - 02/2008
2	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2017 - 02/2008
2	Etoposide (VP 16)FDA LinkGeneric 11/2013 - 02/2003
2	Imatinib Mesylate (Gleevec)FDA Link 01/2010 - 09/2007
2	Protons (Proton)IBA 11/2009 - 04/2007
2	Methotrexate (Mexate)FDA LinkGeneric 02/2007 - 11/2005
2	AntigensIBA 01/2006 - 09/2005
1	belantamab mafodotinIBA 04/2024
1	selinexorIBA 02/2024
1	Immune Checkpoint ProteinsIBA 01/2024
1	ParaffinIBA 10/2023

Therapy/Procedure

46	Therapeutics 10/2023 - 04/2003
18	Stem Cell Transplantation 12/2021 - 07/2004
16	Drug Therapy (Chemotherapy) 10/2015 - 09/2002
7	Highly Active Antiretroviral Therapy (HAART) 02/2008 - 09/2002
5	Aftercare (After-Treatment) 12/2020 - 10/2005
4	Transplantation 01/2023 - 11/2011
3	Immunotherapy 01/2020 - 07/2008
3	Hematopoietic Stem Cell Transplantation 05/2014 - 07/2004
2	Maintenance Chemotherapy 01/2007 - 10/2005